FDA Approved: EPTIFIBATIDE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved Eugia US LLC's original ANDA for Eptifibatide, a GP IIb/IIIa inhibitor used to prevent clot formation in patients with acute coronary syndrome unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

ORIG AP for EPTIFIBATIDE (EPTIFIBATIDE)